XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.23.1

Note 7 - Other Intangible Assets | 3 Months Ended
--- | ---
Mar. 31, 2023
Notes to Financial Statements |
Intangible Assets Disclosure [Text Block] | NOTE 7. OTHER INTANGIBLE ASSETS Other intangible assets consist of the following (in thousands):
|  | Balance at March 31, 2023 |
|  |  |  |  |  | Accumulated |  |  |  |  |  |  |  |  |
|  | Gross |  |  | Amortization |  |  | Impairment |  |  | Net |
Indefinite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade names |  | $ | 2,080 |  |  | $ | — |  |  | $ | (970 | ) |  | $ | 1,110 |
Amortizable intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships |  | $ | 290 |  |  | $ | (51 | ) |  | $ | (172 | ) |  | $ | 67 |
Trade secrets / product formulations |  |  | 2,890 |  |  |  | (410 | ) |  |  | (1,415 | ) |  |  | 1,065 |
Total other intangible assets |  | $ | 5,260 |  |  | $ | (461 | ) |  | $ | (2,557 | ) |  | $ | 2,242 |
|  | Balance at December 31, 2022 |
|  |  |  |  |  | Accumulated |  |  |  |  |  |  |  |  |
|  | Gross |  |  | Amortization |  |  | Impairment |  |  | Net |
Indefinite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade names |  | $ | 2,080 |  |  | $ | — |  |  | $ | (970 | ) |  | $ | 1,110 |
Amortizable intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships |  | $ | 290 |  |  | $ | (48 | ) |  | $ | (172 | ) |  | $ | 70 |
Trade secrets / product formulations |  |  | 2,890 |  |  |  | (375 | ) |  |  | (1,415 | ) |  |  | 1,100 |
Total other intangible assets |  | $ | 5,260 |  |  | $ | (423 | ) |  | $ | (2,557 | ) |  | $ | 2,280 |
In the fourth quarter of 2022, the Company determined that certain of its indefinite-lived and long-lived amortizable intangible assets related to its DERMAdoctor business were impaired. As such, the Company recorded an intangible asset impairment charge of $2.6 million in the fourth quarter of 2022, which was reflected in the “Goodwill, Intangible and Other Asset Impairment” caption in the Company’s consolidated statements of operations. The Company did not record any intangible asset impairment charges for the three months ended March 31, 2023 or 2022. Amortization expense was $38 thousand and $91 thousand for the three months ended March 31, 2023 and 2022, respectively. Based on the amortizable intangible assets as of March 31, 2023, future amortization expenses are expected to be as follows (in thousands):
2023 |  | $ | 114 |
2024 |  |  | 153 |
2025 |  |  | 152 |
2026 |  |  | 153 |
Thereafter |  |  | 560 |
Total |  | $ | 1,132 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350-30/tableOfContent + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration